• 2012

Company Description

Dezima Pharma develops protein-based compounds for treatment of cardiovascular disease related to dyslipidemia.

Dezima Pharma B.V. develops protein-based compounds for treatment of cardiovascular disease related to dyslipidemia. The company was founded in 2012 and is based in Naarden, the Netherlands.